Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999360 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
Achieving negative IFS margins may be associated with survival benefit in patients without residual bladder cancer after RC. Patients who recorded a history of carcinoma in situ before RC are at higher risk to incur positive ureteral margin at IFS and should be investigated during RC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Marco M.D., Andrea M.D., Massimo M.D., Stefano M.D., Nicola M.D., Giorgio M.D., Paolo M.D., Rocco M.D., Vincenzo M.D., Andrea M.D., Francesco M.D., Alberto M.D., Renzo M.D.,